1st Quarter - Report

PFIZER INC. for PFIZER INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$5,340,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 19, 2009 $6,140,000 Replaced
1st Quarter - Report (this page) Jul 27, 2009 $5,340,000 Replaced
1st Quarter - Amendment Oct 20, 2009 $5,340,000 Replaced
1st Quarter - Amendment Sep 21, 2010 $5,860,000 Yes

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
ANTHONY PRINCIPI —

Contacted: Commerce, Dept of (DOC); Defense, Dept of (DOD); State, Dept of (DOS); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Treasury, Dept of; Patent & Trademark Office (PTO)

Trade (domestic/foreign) TRD

US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
STEPHANIE HENNING —
ANTHONY PRINCIPI —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); State, Dept of (DOS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Patent & Trademark Office (PTO); Defense, Dept of (DOD)

Copyright/Patent/Trademark CPT

S. 515, Patent Reform Act of 2009 S. 299, Expert Patent Courts Pilot Program Act, 1/09 S. 369, Preserve Access to Affordable Generics, 2/09 S. 515 Patent Reform Act, 3/09 S.610, Patent Reform Act, 3/09 HR 1260, Patent Reform Act, 3/09 HR 1706, Protecting Consumer Access to Generics Drug Act, 3/09 HR 1548, Pathway for Biosimilars Act

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
JOSEPH DAMOND —
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —

Contacted: Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Treasury, Dept of; Veterans Affairs, Dept of (VA); Commerce, Dept of (DOC)

Bills named: H.R. 1260 (111th), S. 369 (111th), S. 610 (111th), S. 515 (111th), H.R. 1706 (111th), S. 299 (111th), H.R. 1548 (111th)

Health Issues HCR

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Health Information Technology Follow-on Biologics S. 4 - Comprehensive Health reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act HR 2, Children's Health Insurance Program Reauthorization Act of 2009 S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 - Pathway for Biosimilars Act S.717 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H. Con Res 85 - Budget Reconciliation Health Reform Initiatives Health Information Technology Comparative Effectiveness Research Follow on Biologics

Contacted: Defense, Dept of (DOD); Treasury, Dept of; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Veterans Affairs, Dept of (VA); State, Dept of (DOS); Executive Office of the President (EOP); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 501 (111th), H.R. 1 (111th), S. 4 (111th), H.R. 193 (111th), H.R. 1427 (111th), H.Con.Res. 85 (111th), S. 717 (111th), S. 45 (111th), H.R. 15 (111th), H.R. 2 (111th), S.Con.Res. 13 (111th), S. 726 (111th), S. 301 (111th), H.R. 1548 (111th)

Environment/Superfund ENV

Environmental issues related to pharmaceutical manufacturing

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —

Contacted: Commerce, Dept of (DOC); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); State, Dept of (DOS); SENATE; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD)

Consumer Issues/Safety/Products CSP

S.80, Pharmaceutic Market Access Act, 1/09 HR 91, Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 HR 163, The Prescription Drug Affordability Act, 1/09 S. 501, Fair prescription Drug Competition Act, 3/09 S. 767, Independent Drug Education and Outreach Act, 4/09 HR 573, Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09 HR 1427, Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 HR 1548, Pathway for Biosimilars Act, 3/09 HR 759, The Food, drug and Cosmetic Globalization Act, 1/09

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —

Contacted: Veterans Affairs, Dept of (VA); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Food & Drug Administration (FDA); SENATE; Executive Office of the President (EOP); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 767 (111th), H.R. 573 (111th), S. 501 (111th), H.R. 1427 (111th), H.R. 163 (111th), H.R. 1548 (111th), S. 80 (111th), H.R. 91 (111th), H.R. 759 (111th)

Defense DEF

Smoking Cessation Coverage VA Drug Coverage

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
JOHN PAUL HALLIWELL —
LOUIS A LAMARCA —
ANNE WILSON —

Contacted: Food & Drug Administration (FDA); State, Dept of (DOS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Treasury, Dept of; Defense, Dept of (DOD); Commerce, Dept of (DOC); SENATE; Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

S. Con Res 13 - Budget Reconciliation FY 10 H. Con Res 85 - Budget Reconciliation FY 10 Administration budget proposal, deferral and other international tax issues H.R. 1 - The American Recovery and Reinvestment Act 2009

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
JOSEPH DAMOND —
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
KIMBERLY JANE PINTER —
ANTHONY PRINCIPI —
ANNE WILSON —

Contacted: Commerce, Dept of (DOC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); SENATE; Patent & Trademark Office (PTO)

Bills named: H.R. 1 (111th), H.Con.Res. 85 (111th), S.Con.Res. 13 (111th)

Taxation/Internal Revenue Code TAX

HR 1, American Recovery and Reinvestment Act of 2009 - general corporate tax issues HR 198, Healthcare Tax Deduction Act of 2009 - general corporate tax issues HR 422, R&D tax credit extension and Enhancement - R&D tax credit R&D tax credit extension and Enhancement (Senate) - R&D tax credit Deferral

LobbyistCovered position, as disclosed
KIMBERLY JANE PINTER —
ANTHONY PRINCIPI —
ANNE WILSON —

Contacted: Patent & Trademark Office (PTO); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; Veterans Affairs, Dept of (VA); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC)

Bills named: H.R. 198 (111th), H.R. 1 (111th), H.R. 422 (111th)

Medicare/Medicaid MMM

HR 684, The Medicare Prescription Drug Savings and Choice Act of 2009 S. 75, Generics First Act of 2009 (Part D) HR 574, Medicare Home Infusion Therapy Coverage Act of 2009 Medicare Prescription Drug Benefit Implementation - retain Medicaid Rebates - retain the general issues section Medicare Coverage Average Manufacturer Price Regulation

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
DOLLY JUDGE —
ANTHONY PRINCIPI —
ANNE WILSON —

Contacted: State, Dept of (DOS); Health & Human Services, Dept of (HHS); SENATE; Commerce, Dept of (DOC); Treasury, Dept of; Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Patent & Trademark Office (PTO)

Bills named: H.R. 574 (111th), H.R. 684 (111th), S. 75 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.